Recap: Repare Therapeutics Q3 Earnings

Repare Therapeutics RPTX reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Repare Therapeutics beat estimated earnings by 47.67%, reporting an EPS of $-0.45 versus an estimate of $-0.86.

Revenue was down $110.39 million from the same period last year.

Last quarter the company beat on EPS by $0.5 which was followed by a 17.1% increase in the share price the next day.

Here's a look at Repare Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.78	-0.81	-0.97	-0.89
EPS Actual	-0.28	-0.83	-0.75	1.71
Revenue Estimate	7.68M	6.12M	10.83M	1.58M
Revenue Actual	30.25M	5.68M	18.20M	112.55M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Repare Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar